Irinotecan (CPT-11) in combination with raltitrexed (TX) in patients with previously untreated, advanced colorectal cancer (ACC) patients.: Preliminary results of a phase I/II trial.

被引：0
|
作者：
Losa, F
Manzano, H
Vicente, P
Rifa, J
Ocaña, J
Balcells, M
Mediavilla, D
Heras, L
机构：
[1] Hosp creu Roja, Lhospitalet De Llobregat, Spain
[2] Hosp Son Dureta, Palma de Mallorca, Spain
[3] Hosp Gen Granollers, Granollers, Spain
[4] Almirall Prodesfarma SA, Barcelona, Spain
[5] Rec Clin SL, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3675
引用
收藏
页码：288S / 288S
页数：1
相关论文
共 50 条
  • [31] A phase II trial of irinotecan, 5-fluorouracil and leucovorin in patients with previously untreated advanced colorectal cancer (CRC)
    Lee, N.
    Bae, S.
    Lee, S.
    Kim, D.
    Kim, K.
    Kim, H.
    Kim, C.
    Lee, K.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Phase II trial of irinotecan (CPT-11) and radiation followed by irinotecan and BCNU in glioblastoma patients (pts).
    Ballman, K. V.
    Jaeckle, K. A.
    Schomberg, P.
    Giannini, C.
    Galanis, E.
    Brown, P.
    Arusell, R.
    Reid, J.
    Hammack, J.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 73S - 73S
  • [33] Phase I and pharmacokinetic (PK) study of irinotecan (CPT-11) and cisplatin in patients with solid tumors: Preliminary results
    deJonge, MJA
    Sparreboom, A
    Planting, AST
    vanderBurg, MEL
    deBruijn, P
    Brouwer, E
    vanBeurden, V
    vanDuijn, MR
    Jacques, C
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1134 - 1134
  • [34] EFFICACY OF COMBINATION CHEMOTHERAPY WITH IRINOTECAN (CPT-11) PLUS CAPECITABINE IN PATIENTS WITH METASTATIC OR ADVANCED COLORECTAL CARCINOMA
    Gennatas, C.
    Michalaki, V.
    Gennatas, S.
    Voros, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 148 - 148
  • [35] Phase II trial of a combination chemotherapy of CPT-11 and S-1 in patients with advanced/recurrent colorectal cancer (OGSG-0405)
    Tomita, N.
    Okamura, S.
    Nakata, K.
    Murata, K.
    Tokunaga, Y.
    Umeki, M.
    Takiuchi, H.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Randomized phase II study of CPT-11 plus mitomycin C versus oxaliplatin plus mitomycin C in previously treated patients with advanced colorectal cancer (ACC)
    Ulrich-Pur, H
    Brugger, S
    Kornek, GV
    Fiebiger, W
    Haider, K
    Kwasny, W
    Depisch, D
    Kovats, E
    Lang, F
    Scheithauer, W
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S72 - S73
  • [37] Phase II study of irinotecan (CPT-11) in patients with advanced colorectal cancer resistant to 5-fluorouracil based chemotherapy.
    Salinas, P
    Lara, MA
    de Septién, CFM
    Feliu, J
    Espinosa, E
    de Castro, J
    García-Girón, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S76 - S76
  • [38] A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix
    Irvin, WP
    Price, FV
    Bailey, H
    Gelder, M
    Rosenbluth, R
    Durivage, HJ
    Potkul, RK
    CANCER, 1998, 82 (02) : 328 - 333
  • [39] Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors
    Font, A
    Sanchez, JM
    Rosell, R
    Taron, M
    Martinez, E
    Guillot, M
    Manzano, JL
    Margeli, M
    Barnadas, A
    Abad, A
    LUNG CANCER, 2002, 37 (02) : 213 - 218
  • [40] Celecoxib in combination with irinotecan (CPT-11), 5-fluorouracil and leucovorin in patients with advanced cancer: A phase I, pharmacokinetic study.
    Creaven, PJ
    Javle, MM
    Pendyala, L
    Smith, P
    Noel, DC
    Iyer, RV
    Lawrence, DD
    Rustum, YM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 157S - 157S
12345